Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

9.65
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
8.07
Today|||52-Week Range
18.00
-30.22%
Year-to-Date

Today’s Trading

Previous close9.65
Today’s open9.94
Day’s range9.54 - 10.19
Volume763,005
Average volume (3 months)752,955
Market cap$1.0B
Dividend yield--
Data as of 4:00pm ET, 11/17/2017

Growth & Valuation

Earnings growth (last year)-2,620.00%
Earnings growth (this year)-1.01%
Earnings growth (next 5 years)+30.87%
Revenue growth (last year)-35.90%
P/E ratioNM
Price/Sales17.24
Price/Book6.39

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...0.000.00%
RGENRepligen Corp0.000.00%
EBSEmergent BioSolution...0.000.00%
ARRYArray Biopharma Inc0.000.00%
Data as of 4:02pm ET, 11/17/2017

Financials

Next reporting dateMarch 2, 2018
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$83.3M
Annual profit (last year)-$141.4M
Net profit margin-169.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Lonnel Coats
CFO, EVP-Corporate &
Administrative Affairs
Jeffrey L. Wade
Corporate headquarters
The Woodlands, Texas

Forecasts